Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema

• Published in: The Journal of thoracic and cardiovascular surgery Vol. 112; no. 5; pp. 1319 - 1330
• Main Authors: Cooper, Joel D., Patterson, G.Alexander, Sundaresan, R.Sudhir, Trulock, Elbert P., Yusen, Roger D., Pohl, Mary S., Lefrak, Stephen S.
• Format: Journal Article
• Language: English
• Published: United States Mosby, Inc 01.11.1996; AATS/WTSA
• Subjects: Adult; Aged; Dyspnea - etiology; Dyspnea - physiopathology; Humans; Middle Aged; Pneumonectomy; Pulmonary Emphysema - complications; Pulmonary Emphysema - physiopathology; Pulmonary Emphysema - surgery; Quality of Life; Respiratory Mechanics; Retrospective Studies; Surgical Stapling; Treatment Outcome
• ISSN: 0022-5223; 1097-685X
• DOI: 10.1016/S0022-5223(96)70147-2

Between January 1993 and February 1996, we performed 150 bilateral lung volume reduction procedures for patients with severe emphysema. Patients were selected on the basis of severe dyspnea, increased lung capacity, and a pattern of emphysema that included regions of severe destruction, hyperinflation, and poor perfusion. Twenty percent to 30% of the volume of each lung was excised with the use of a linear stapler and bovine pericardial strips attached to buttress the staple line. Patients were between 36 and 77 years old, with an average 1-second forced expiratory volume of 25% of predicted, total lung capacity of 142% of predicted, and residual volume of 283% of predicted. Ninety-three percent of patients required supplemental oxygen, continuously or with exertion. All patients but one were extubated at the end of the procedure. The 90-day mortality was 4%. Hospital stay progressively decreased with experience, and for the last 50 patients the median hospital stay was 7 days. Prolonged air leakage was the major complication. Results at 6 months show a 51% increase in the 1-second forced expiratory volume and a 28% reduction in the residual volume. The Pao 2 increased by an average of 8 mm Hg, and 70% of the patients who had previously required continuous supplemental oxygen no longer had this requirement. The improvements in measured pulmonary function were paralleled by a significant reduction in dyspnea and an improvement in the quality of life. Reevaluation at 1 year and 2 years after operation showed the benefit to be well maintained. We conclude that lung volume reduction offers benefits not achievable by any means other than lung transplantation for highly selected patients with severe emphysema. (J T HORAC C ARDIOVASC S URG 1996;112:1319-30)